Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Myriad Genetics

WKN: 897518 / Symbol: MYGN / Name: Myriad Genetics / Stock / Healthcare Equipment & Supplies / Mid Cap /

€2.71
-1.280%

Genetic Technologies Ltd.

WKN: 893882 / Symbol: GNTLF / Name: Genetic / Stock / Biotechnology & Medical Research / Micro Cap /

€0.049
164.860%

Atossa Genetics Inc

WKN: A2JJ99 / Symbol: ATOS / Name: Atossa Genetics / Stock / Healthcare Equipment & Supplies / Micro Cap /

€0.48
-5.220%

Fulgent Genetics Inc

WKN: A2AS4N / Symbol: FLGT / Name: Fulgent Genetics / Stock / Healthcare Equipment & Supplies / Micro Cap /

€17.10
2.480%

Genetic Analysis As

WKN: A3C4C1 / Name: Genetic Analysis As / Stock / ? /

€0.044
-0.450%

Sophia Genetics S.a.

WKN: A3CVT8 / Name: Sophia Genetics S.a. / Stock / ? /

€7.05
0.000%

Applied Genetic Technologies Corp.

WKN: A110V2 / Symbol: AGTC / Name: AGTC / Stock / Biotechnology & Medical Research / Small Cap /

€0.37
-0.820%

Lumos Pharma Inc.

WKN: A2P12E / Symbol: NLNK / Name: Lumos Pharma / Stock / Biotechnology & Medical Research / Small Cap /

€4.16
-0.490%

SOPHiA GENETICS Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
SOPHiA GENETICS Q2 Earnings Call Highlights

Key Points

Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates
Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.12 per share a year ago. These

Seagen Inc.

WKN: A2QFAQ / Symbol: SGEN / Name: Seagen / Stock / Biotechnology & Medical Research / Large Cap /

€210.40
-0.850%

miRagen Therapeutics Inc

WKN: A2QJB7 / Name: miRagen Therapeutics / Stock / Small Cap /

€16.54
-4.590%

Vyant Bio Inc.

WKN: A3DZJZ / Symbol: VYNT / Name: Vyant Bio / Stock / Healthcare Providers & Services / Micro Cap /

€0.13
-

BMY or AMGN: Which Is the Better Value Stock Right Now?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
BMY or AMGN: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Bristol Myers Squibb (BMY) and Amgen (AMGN). But which of these two stocks is more attractive to

REGN or INCY: Which Is the Better Value Stock Right Now?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
REGN or INCY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Regeneron (REGN) or Incyte (INCY). But which of these two stocks is more attractive to

JAZZ vs. TECH: Which Stock Is the Better Value Option?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
JAZZ vs. TECH: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Jazz Pharmaceuticals (JAZZ) and Techne (TECH). But which of these two stocks presents investors

BMRN vs. ILMN: Which Stock Is the Better Value Option?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
BMRN vs. ILMN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or Illumina (ILMN). But which of these two companies is the

Pelthos Therapeutics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Pelthos Therapeutics Q2 Earnings Call Highlights

Key Points

KMDA or PRTA: Which Is the Better Value Stock Right Now?Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
KMDA or PRTA: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Prothena (PRTA). But which of these two companies is the best option for those looking for